Skip to main content
. Author manuscript; available in PMC: 2022 May 16.
Published in final edited form as: Cancer Drug Resist. 2022 Jan 4;5:80–89. doi: 10.20517/cdr.2021.112

Figure 1.

Figure 1.

Schema for developing resistance to VAC therapy in mice using the single mouse study design. Mice received a single cycle of VAC (vincristine, actinomycin D, cyclophosphamide). Tumor response was determined, and tumors were transplanted in recipient mice when they achieved 400% of their volume on the first day of treatment.